linsidomine has been researched along with 1,2-dithiol-3-thione in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; Li, Y | 1 |
| Gabrielson, KL; Jia, Z; Li, Y; Misra, HP; Santo, A; Zhou, K; Zhu, H | 1 |
2 other study(ies) available for linsidomine and 1,2-dithiol-3-thione
| Article | Year |
|---|---|
Protecting against peroxynitrite-mediated cytotoxicity in vascular smooth muscle cells via upregulating endogenous glutathione biosynthesis by 3H-1,2-dithiole-3-thione.
Topics: Animals; Antineoplastic Agents; Buthionine Sulfoximine; Cell Survival; Cells, Cultured; Dipeptides; Dose-Response Relationship, Drug; Drug Antagonism; Drug Combinations; Glutathione; Molsidomine; Muscle, Smooth, Vascular; Peroxynitrous Acid; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiones; Thiophenes; Up-Regulation | 2004 |
Cruciferous dithiolethione-mediated coordinated induction of total cellular and mitochondrial antioxidants and phase 2 enzymes in human primary cardiomyocytes: cytoprotection against oxidative/electrophilic stress and doxorubicin toxicity.
Topics: Aldehydes; Antineoplastic Agents; Antioxidants; Cell Line; Cytoprotection; Doxorubicin; Humans; Metabolic Detoxication, Phase II; Mitochondria; Molsidomine; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species; Thiones; Thiophenes; Up-Regulation; Xanthine Oxidase | 2009 |